ADGM — Adagio Medical Holdings, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 2006986 ·
Last close
$1.65
Market Cap
$36.65M
52W High
$50.70
52W Low
$1.45
ADV30
120,293
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 0 | -4,371,000 | 17,840,000 | 29,860,000 | 3,095,000 | 11,497,000 |
| Jun 2026 | 0 | 0 | -4,934,000 | -6,717,000 | 33,884,000 | 7,740,000 | 34,299,000 |
| Mar 2026 | 0 | 0 | -5,200,000 | -6,995,000 | 39,308,000 | 12,909,000 | 33,583,000 |
| Dec 2025 | 0 | -58,000 | -3,968,000 | -3,306,000 | 43,253,000 | 17,105,000 | 30,851,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-16,533,000
Investing CF
$-37,000
Financing CF
$16,134,000
CapEx
$-538,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.48
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-109,403,000
Inventory
$1,986,000
Receivables
$0
ST Investments
—
EBIT TTM
$-24,029,000
Pretax Income TTM
$-27,136,000
Interest Exp TTM
$3,107,000
Analysts
2
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -21,890,000 | -25,084,000 | 43,253,000 | 30,851,000 | 12,402,000 | -19,014,000 |
| Dec 2024 | — | — | — | 48,448,000 | 28,536,000 | 19,912,000 | — |
| Dec 2023 | 300,000 | -27,942,000 | -38,146,000 | 6,825,000 | 138,848,000 | -132,023,000 | -25,652,000 |
| Dec 2022 | 189,000 | -23,913,000 | -23,673,000 | 8,697,000 | 104,574,000 | -95,877,000 | -22,412,000 |
| Dec 2021 | 270,000 | -20,645,000 | -19,938,000 | — | — | — | -19,307,000 |
TTM Snapshot
Revenues TTM
$-266,000
NetIncome TTM
$-27,136,000
OpCashFlow TTM
—
Assets (Latest)
$33,884,000
Forward EPS
$-1.16
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MYO | MYOMO, INC. | $36.85M | $0.92 | — |
| NXGL | NEXGEL, INC. | $37.04M | $3.80 | — |
| SRTS | Sensus Healthcare, Inc. | $37.20M | $2.26 | — |
| MCAG | Mountain Crest Acquisition Corp. V | $38.13M | $13.27 | — |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | $38.54M | $1.90 | — |
News headlines (Yahoo Finance, 1h cache)
Adagio Medical Reports Third Quarter 2026 Results
2026-11-16 13:00 · Yahoo
Adagio Medical Provides Business Update: 22 Patients Treated with Next-Generation vCLAS™ Ultra System as FULCRUM-VT IDE Sub-Study Advances
2026-11-10 13:00 · Yahoo
Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
2026-09-23 12:00 · Yahoo
Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix
2026-09-16 12:00 · Yahoo
Adagio Medical Reports Second Quarter 2026 Results
2026-08-11 12:30 · Yahoo
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System
2026-08-03 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.